Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older.

JS, Koo; SH, Moon; H, Lee; S, Park; YM, Yu; HY, Kang

doi:10.1371/journal.pone.0244759

Public

Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older.

Shared by NobleBlocks on Dec 31, 2020 • 12:00 AM UTC

Authors:

Koo JS

Moon SH

Lee H

Abstract

<h4>Introduction</h4>The Korean National Health Insurance revised its reimbursement criteria to expand coverage for anti-osteoporotic drug treatments in 2011 (expanding diagnostic criteria and the coverage period for anti-osteoporotic therapy) and 2015 (including osteoporotic fracture patients regar...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!